Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction
Status:
Terminated
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of ranolazine, an FDA-approved
medication for the treatment of angina, on heart function by using echocardiography.